Clinical trial
Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After…
NCT00004853 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00004853 |
|---|---|
| Title | Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy |
| Official title | A Randomized Trial of Filgrastim-SD/01 vs. Filgrastim in Newly Diagnosed Children and Young Adults With Sarcoma Treated With Dose-Intensive Chemotherapy |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ewing's Sarcoma, Rhabdomyosarcoma, MPNST, Synovial Sarcoma, High-risk Sarcoma |
| Intervention type | Biological |
| Interventions | Filgrastim, Filgrastim-SD/01 |
| Enrollment | 34 |
| Start date | Mar 3, 2000 |
| Primary completion | May 20, 2009 |
| Completion | May 20, 2009 |
| First posted | Mar 6, 2000 |
| Last update posted | Nov 12, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: